Comparing Joint (NASDAQ:JYNT) and Eurofins Scient (OTCMKTS:ERFSF)

Joint (NASDAQ:JYNTGet Free Report) and Eurofins Scient (OTCMKTS:ERFSFGet Free Report) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations and profitability.

Valuation & Earnings

This table compares Joint and Eurofins Scient”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Joint $54.90 million 2.17 $2.91 million $0.27 31.22
Eurofins Scient $8.25 billion 1.89 $537.29 million N/A N/A

Eurofins Scient has higher revenue and earnings than Joint.

Volatility & Risk

Joint has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. Comparatively, Eurofins Scient has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Joint and Eurofins Scient, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Joint 1 2 0 0 1.67
Eurofins Scient 0 2 1 0 2.33

Profitability

This table compares Joint and Eurofins Scient’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Joint 6.49% 12.02% 3.47%
Eurofins Scient N/A N/A N/A

Insider and Institutional Ownership

76.9% of Joint shares are held by institutional investors. 30.2% of Joint shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Joint beats Eurofins Scient on 7 of the 11 factors compared between the two stocks.

About Joint

(Get Free Report)

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

About Eurofins Scient

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.